Insider Selling: Intuitive Surgical, Inc. (NASDAQ:ISRG) EVP Sells 11,545 Shares of Stock

Intuitive Surgical, Inc. (NASDAQ:ISRG) EVP Robert Desantis sold 11,545 shares of the company’s stock in a transaction on Thursday, March 13th. The shares were sold at an average price of $499.22, for a total value of $5,763,494.90. Following the sale, the executive vice president now owns 5,224 shares of the company’s stock, valued at approximately $2,607,925.28. The trade was a 68.85 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink.

Intuitive Surgical Price Performance

Shares of ISRG opened at $484.44 on Friday. Intuitive Surgical, Inc. has a 1 year low of $364.17 and a 1 year high of $616.00. The company has a market capitalization of $172.55 billion, a price-to-earnings ratio of 75.58, a price-to-earnings-growth ratio of 5.85 and a beta of 1.43. The business has a 50-day moving average of $567.46 and a 200-day moving average of $531.26.

Hedge Funds Weigh In On Intuitive Surgical

A number of hedge funds have recently made changes to their positions in the stock. Lansforsakringar Fondforvaltning AB publ bought a new position in shares of Intuitive Surgical during the fourth quarter worth about $109,345,000. PKO Investment Management Joint Stock Co bought a new position in shares of Intuitive Surgical during the fourth quarter worth about $1,566,000. IronOak Wealth LLC. acquired a new stake in Intuitive Surgical during the fourth quarter worth approximately $1,595,000. TFR Capital LLC. acquired a new stake in Intuitive Surgical during the fourth quarter worth approximately $3,252,000. Finally, Siemens Fonds Invest GmbH grew its stake in Intuitive Surgical by 795.2% during the fourth quarter. Siemens Fonds Invest GmbH now owns 143,818 shares of the medical equipment provider’s stock worth $75,067,000 after purchasing an additional 127,753 shares during the period. 83.64% of the stock is currently owned by institutional investors.

Wall Street Analyst Weigh In

A number of analysts have recently weighed in on ISRG shares. Piper Sandler reiterated an “overweight” rating and set a $670.00 target price (up from $538.00) on shares of Intuitive Surgical in a research report on Friday, January 24th. Morgan Stanley raised Intuitive Surgical from an “equal weight” rating to an “overweight” rating and boosted their price target for the stock from $522.00 to $650.00 in a report on Monday, December 2nd. Erste Group Bank raised Intuitive Surgical from a “hold” rating to a “buy” rating in a report on Tuesday, November 19th. Barclays boosted their price target on Intuitive Surgical from $610.00 to $674.00 in a report on Monday, January 27th. Finally, Jefferies Financial Group boosted their price target on Intuitive Surgical from $475.00 to $575.00 in a report on Monday, January 27th. One research analyst has rated the stock with a sell rating, four have issued a hold rating and sixteen have given a buy rating to the company. According to data from MarketBeat.com, Intuitive Surgical currently has a consensus rating of “Moderate Buy” and a consensus target price of $613.10.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.